Is there randomized controlled trial evidence comparing the efficacy and safety of tPA versus aspirin in the treatment of acute ischemic stroke?

Current evidence from systematic reviews and meta-analyses indicates no significant difference in functional outcomes between tPA and aspirin for minor strokes, with aspirin having a lower trend in symptomatic hemorrhage. However, direct RCTs specifically designed to compare these treatments in broader acute ischemic stroke populations are limited.